Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors / 肿瘤防治研究
Cancer Research on Prevention and Treatment
; (12): 794-798, 2021.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-988450
Biblioteca responsável:
WPRO
ABSTRACT
Cardiotoxicity is a serious complication of antineoplastic drugs. With the continuous development of antineoplastic drugs, immune checkpoint inhibitors have been used in the treatment of a variety of cancers. PD-1/PD-L1 immune checkpoint inhibitors have been widely concerned in recent years. This article reviews the manifestations and possible mechanisms of cardiotoxicity induced by PD-1/PD-L1 immune checkpoint inhibitors, and the detection methods and treatment of cardiotoxicity.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Cancer Research on Prevention and Treatment
Ano de publicação:
2021
Tipo de documento:
Artigo